|
PHT to
use Palm m500 for Data Capture In Clinical Trials
|
SANTA CLARA, Calif., March 26 Palm, Inc. a provider of handheld
computers, and PHT Corporation, the leader in eClinical Trials and
mobile clinical data capture, announced that PHT Corporation has
purchased 3,000 Palm m500 handheld computers. Additionally, PHT
Corporation has agreed to purchase approximately 13,000 more Palm
m500 handhelds over the course of this calendar year. PHT Corporation
serves the biopharmaceutical industry and provides eClinical Trial
technology that is used by some of the largest pharmaceutical companies
in the world.
Worldwide, patients and investigators, such as doctors or nurses,
will use the Palm handhelds to record data collected in clinical
trials. The handhelds are configured by PHT to collect information
for the trial in a way that makes data collection easy and convenient
for patients and doctors. The configured
handhelds are referred to as Esendant LogPads by PHT during the
trials. Patients answer questions and enter requested information
and symptoms as they
occur. After completing their report, patients or doctors attach
a modem and send the collected data back to PHT's StudyServer, where
authorized personnel can view and analyze the information securely
over the web via Esendant StudyWorks, PHT's web-based electronic
data capture and management product.
"The FDA sets tough security and reliability standards for
handhelds used in clinical trials," said Steve Raymond, chief
scientist at PHT Corporation. "We chose Palm handhelds for
all of our clinical trials worldwide because they were the only
handhelds to pass all of the FDA and other requirements we must
meet."
PHT Corporation, which has been using Palm handhelds in their clinical
trials since June 2000, reports that the use of Palm handhelds in
clinical trials has increased ten-fold the compliance levels achieved
by study participants. It also saves the cost of manual data collection
and improves the quality of the data being collected, so drugs can
get to market faster and more safely. Esendant LogPad, developed
by PHT, supports multiple languages and has been used in more than
14 therapeutic areas by more than 12,000 patients and 900 investigators
in clinical trials worldwide.
About PHT Corporation
PHT Corporation is a leading technology provider of eClinical Trials
and mobile clinical data capture products that are designed to support
the vision of transforming clinical research through innovative
technology. Some of the world's largest pharmaceutical, biotech
and medical device companies are using
PHT's Esendant Clinical Network technology to improve the data capture,
safety, and speed of the clinical trial process. PHT is headquartered
in
Charlestown, Mass. with a European office in Geneva, Switzerland,
and can be found on the Web at http://www.phtcorp.com.
|
|